Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

New England Journal of Medicine

Volumn 348, Issue 14, 2003, Pages 1342-1347

  Chang, Soju ^a   Sievert, Dawn M ^c   Hageman, Jeffrey C ^b   Boulton, Matthew L ^c   Tenover, Fred C ^b   Downes, Frances Pouch ^c   Shah, Sandip ^c   Rudrik, James T ^c   Pupp, Guy R ^d   Brown, William J ^e   Cardo, Denise ^b   Fridkin, Scott K ^b,f  

^a Epidemiology and Analysis Program Office   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^d Lakeview Podiatry Associates   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; GATIFLOXACIN; LINEZOLID; MINOCYCLINE; ORITAVANCIN; PSEUDOMONIC ACID; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE REPORT; FEMALE; GENE; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VANA GENE;

EID: 0037417230     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa025025     Document Type: Article

References (21)

1. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR Morb Mortal Wkly Rep 1997;46:624-6.
2. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493-501.
3. Rotun SS, McMath V, Schoonmaker DJ, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 1999;5:147-9.
4. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001;32:108-15.
5. Staphylococcus aureus with reduced susceptibility to vancomyein - Illinois, 1999. MMWR Morb Mortal Wkly Rep 2000;48:1165-7.
6. Hageman JC, Pegues DA, Jepson C, et al. Vancomycin-intermediate Staphylococcus aureus in a home health-care patient. Emerg Infect Dis 2001;7:1023-5.
7. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Vol. 17. Wayne, Pa.: National Committee for Clinical Laboratory Standards, 2000.
8. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:565-7.
9. Kloos WE, Bannerman TL. Staphylococcus and Microroccus. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:264-82.
10. Vannuffel P, Gigi J, Ezzedine H, et al. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol 1995;33:2864-7.
11. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993; 37:2311-7.
12. Ostrowsky BE, Clark NC, Thauvin-Eliopoulos C, et al. A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. J Infect Dis 1999;180:1177-85.
13. Weigel LM, Anderson GJ, Facklam RR, Tenover FC. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2001;45:3517-23.
14. Bannerman TL, Hancock GA, Tenover FC, Miller JM. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 1995; 33:551-5.
15. Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, D.C.: American Society for Microbiology, 1993:563-72.
16. Garner JS. Guideline for isolation precautions in hospitals. I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996;24:24-31.
17. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 2001;50(RR-5):1-43.
18. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tnl546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993;175:117-27.
19. Noble WC, Virani Z, Cree RG. Co-transfer ofvancomycin and other resistance genes from Enterococcusfaecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbial Lett 1992; 72:195-8.
20. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995;44 (RR-12):1-13.
21. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep 1997;46:626-8, 635.